Mov Disord Vol 33, Suppl 2 Archives - Page 18 of 177 - MDS Abstracts

2018 International Congress
A panel of CSF and plasma biomarkers reveals novel biological insights into atypical parkinsonian syndromes
E. Jabbari, J. Woodside, N. Magdalinou, A. Lees, H. Zetterberg, H. (London, United Kingdom)
Objective: Our study aims to identify diagnostic markers of atypical parkinsonian disorders that offer novel insights into these conditions. In particular, we wish to use…
2018 International Congress
Consensus for the measurement of the camptocormia angle
N. Margraf, R. Wolke, O. Granert, A. Berardelli, D. Berg, B. Bloem, R. Djaldetti, A. Espay, A. Fasano, Y. Furusawa, N. Giladi, M. Hallett, J. Jankovic, M. Murata, M. Tinazzi, J. Volkmann, G. Deuschl (Kiel, Germany)
Objective: To define a consensus-based and clinically applicable method for measuring the camptocormia angle. Background: Camptocormia is characterized by a pathological forward bending of the…
2018 International Congress
Evaluating the impact of the educational course for nurses on Parkinson’s disease: A model for continuing nursing education
S. Phumphid, O. Jitkritsadakul, R. Bhidayasiri (Bangkok, Thailand)
Objective: To evaluate the level of general PD knowledge among the nursing community and to determine the impact of a PD educational program on their…
2018 International Congress
There’s “still life after Parkinson’s”: A qualitative analysis of the Australian Sing to Beat Parkinson’s® project
D. Stewart, J. Irons, G. Hancox (South Brisbane, Australia)
Objective: To investigate the perceptions and views of people with Parkinson’s (PWP) and their carers after completing a six month weekly group singing intervention. Background:…
2018 International Congress
REM Sleep Behavior Disorder Associations with Parkinson’s Disease Study (RAPiDS): Initial Baseline Data
D. Barone, H. Sarva, L. Ravdin, M. Vo, A. Hanineva, M. DeGrazia, A. Krieger, N. Hellmers, C. Henchcliffe (New York, NY, USA)
Objective: To examine association of clinical and neurophysiological characteristics associated with synucleinopathies in a cohort of adult subjects with REM sleep Behavior Disorder (RBD) and…
2018 International Congress
“Appropriate Doses Treatment” of IncobotulinumtoxinA in spasticity
G. Ianieri, R. Marvulli (Bari, Italy)
Objective: The aim of this study is to object the efficiency and safety of 100 to 1000 units botulinum toxin treatment with modulation of spasticity…
2018 International Congress
The Use of eConsult in a Movement Disorders Clinic
D. Grimes, A. Ohman, C. Liddy, E. Keely, A. Afkhim, T. Mestre (Ottawa, ON, Canada)
Objective: To assess the use of eConsults in a Movement Disorders clinic. Background: The availability of specialized care in most regions is limited and novel…
2018 International Congress
Safety and efficacy of high definition tDCS for proprioception and balance in Parkinson’s disease: A pilot randomised trial
H. Teasdale, E. Preston, A. Flood, G. Waddington (Canberra, Australia)
Objective: To determine: 1. Is HD-tDCS safe and well-tolerated in PD? 2. Does combined HD-tDCS and physical exercise improve proprioception and balance in PD? Background:…
2018 International Congress
Which is the best condition to evaluate the decline in gait automaticity in people with Parkinson’s disease? A ParkiMob study
M. d'Alencar, Y. Uscapi, J. Miranda, M. Piemonte (São Paulo, Brazil)
Objective: To identify which is the most efficient condition in terms of distance and kind of concurrent task to identify the decline in gait automaticity…
2018 International Congress
Accelerometer-based measures and analyses of nonmotor symptoms of patients with Parkinson’s Disease
C. Virbel-Fleischman, Y. Retory, S. Hardy, J.C. Corvol, D. Grabli (Paris, France)
Objective: Through the monitoring of patients with PD during ON and OFF states, we aim at studying the detection of nonmotor symptoms (NMS) changes during…